Heron Therapeutics Inc (HRTX)
1.07
+0.01
(+0.94%)
USD |
NASDAQ |
Nov 22, 16:00
1.07
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Debt to Equity Ratio: -4.361 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | -4.361 |
| June 30, 2024 | -4.592 |
| March 31, 2024 | -5.153 |
| December 31, 2023 | -5.114 |
| September 30, 2023 | -6.243 |
| June 30, 2023 | -3.803 |
| March 31, 2023 | -13.07 |
| December 31, 2022 | 11.00 |
| September 30, 2022 | 6.647 |
| June 30, 2022 | -6.863 |
| March 31, 2022 | 6.225 |
| December 31, 2021 | 1.922 |
| September 30, 2021 | 1.254 |
| June 30, 2021 | 0.9305 |
| March 31, 2021 | 0.0385 |
| December 31, 2020 | 0.0298 |
| September 30, 2020 | 0.0239 |
| June 30, 2020 | 0.0193 |
| March 31, 2020 | 0.0162 |
| December 31, 2019 | 0.0139 |
| September 30, 2019 | 0.0188 |
| June 30, 2019 | 0.0166 |
| March 31, 2019 | 0.0145 |
| December 31, 2018 | 0.0124 |
| September 30, 2018 | 0.0107 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0674 |
| March 31, 2018 | 0.3134 |
| December 31, 2017 | 0.2187 |
| September 30, 2017 | 0.7111 |
| June 30, 2017 | 0.4095 |
| March 31, 2017 | 0.5197 |
| December 31, 2016 | -2.490 |
| September 30, 2016 | 2.949 |
| June 30, 2016 | 0.0442 |
| March 31, 2016 | 0.0258 |
| December 31, 2015 | 0.0188 |
| September 30, 2015 | 0.0145 |
| June 30, 2015 | 0.0119 |
| March 31, 2015 | 0.0364 |
| December 31, 2014 | 0.0253 |
| September 30, 2014 | 0.0179 |
| June 30, 2014 | 0.0133 |
| March 31, 2014 | 0.021 |
| December 31, 2013 | 0.0149 |
| September 30, 2013 | 0.0425 |
| June 30, 2013 | 0.0265 |
| March 31, 2013 | 0.015 |
| December 31, 2012 | 0.0095 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-13.07
Minimum
Mar 2023
11.00
Maximum
Dec 2022
-1.054
Average
0.0178
Median
Debt to Equity Ratio Benchmarks
| Journey Medical Corp | 1.811 |
| NovaBay Pharmaceuticals Inc | 0.0476 |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 220.78M |
| Total Liabilities (Quarterly) | 260.78M |
| Shareholders Equity (Quarterly) | -40.00M |
| Current Ratio | 2.282 |
| Net Debt Paydown Yield | -1.66% |